Skip to main content
. 2022 Jan 14;12:805883. doi: 10.3389/fimmu.2021.805883

Figure 5.

Figure 5

Comparison of immune signature between the high-risk and low-risk groups of EC patients. (A) The infiltration of 21 types of immune cells in high-risk and low-risk groups was estimated by TIMER, CIBERSORT, CIBERSORT-ABS, QUANTISEQ, MCPCOUNTER, XCELL, and EPIC database. (B, C) Comparison of tumor-infiltrating immune cells between different risk groups. (D) The correlation of risk score and tumor-infiltrating immune cells. EC, endometrial cancer.